7160-22-7

Usage

Uses

Used in Organic Synthesis:
3',4'-DICHLOROPIVALANILIDE is used as a building block in organic synthesis for the preparation of various chemical compounds. Its unique structure allows for the creation of a wide range of molecules with diverse applications.
Used in Medicinal Chemistry:
3',4'-DICHLOROPIVALANILIDE is used as a precursor in the preparation of pharmaceutical compounds. Its chemical properties make it a promising candidate for the development of new drugs with potential therapeutic applications.
Used in Pesticide Industry:
3',4'-DICHLOROPIVALANILIDE is used as an insecticide and herbicide due to its potential biological activity. Its ability to control pests and weeds makes it a valuable tool in agriculture and crop protection.
Used in Chemical Research:
3',4'-DICHLOROPIVALANILIDE is used in chemical research to study its properties and explore its potential applications. Its unique structure and reactivity make it an interesting subject for scientific investigation.

Upstream product

• 3282-30-2 pivaloyl chloride 
• 95-76-1 m,p-dichloroaniline 

Downstream Products

• 361392-60-1 2-tert-butyl-6-chloro-benzooxazole-7-sulfonyl chloride 
• 955974-44-4 6-amino-3-chloro-2-((5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)sulfonyl)phenol 
• 955974-40-0 C₁₆H₂₂ClN₃O₅S 
• 955974-38-6 C₂₁H₂₈ClN₃O₅S 
• 955974-41-1 C₂₃H₂₅Cl₂FN₄O₆S 
• 954127-42-5 C₁₆H₂₃ClN₂O₅S 

Relevant academic research and scientific papers

CXCR2 ANTAGONIST

A compound as a CXCR2 antagonist and an application thereof in preparing a drug as a CXCR2 antagonist. In particular, the present invention relates to a compound represented by formula (II) or an isomer or pharmaceutically acceptable salt thereof.

Rhodium(III)-catalysed, redox-neutral C(sp2)-H alkenylation using pivalimide as a directing group with internal alkynes

In the presence of [RhCp?Cl2]2, N-pivaloyl anilines react with internal alkynes to give the corresponding 2-alkenylpivalimides under redox neutral conditions through C-H activation. This redox neutral hydroarylation, which does not require an external organic acid, unlocks a regioselective synthetic route to 2-alkenyl anilines and is generally applicable to diversely substituted electron rich and electron poor pivalimides.

A unified strategy for silver-, base-, and oxidant-free direct arylation of C-H bonds

Here, we report a dual catalytic approach for room temperature direct arylation of C-H bonds with aryldiazonium salts as a simple aryl group donor, also working as an internal oxidant via C-N2 bond cleavage. This unified strategy has been achieved by the synergistic combination of visible-light metal-free photoredox and palladium catalysis under silver-, base- and/or additive-free conditions. The broad substrate scope, functional group tolerance, excellent regioselectivity and redox-neutral conditions of this process make it attractive for the effective synthesis of a wide range of important N-heterocyclic commodities such as dibenzo[b,d]azepine, carbazole and phenanthridine.

METHOD OF TREATMENT

This invention relates to the use of a sulfonamide substituted diphenyl urea compound to treat cystic fibrosis, or the symptoms associated with cystic fibrosis.

IL-8 Receptor Antagonists

This invention relates to novel compounds and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).

METHOD OF TREATMENT

This invention relates to the use of sulfonamide substituted diphenyl urea compounds to treat endometriosis.

Il-8 receptor antagonists

This invention relates to the novel use of sulfonamide squaramides in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).

Il-8 receptor anatagonists

This invention relates to novel compounds of Formula (I), and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).

Il-8 receptor antagonists

This invention relates to novel compounds of Formula (I), and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).

Il-8 receptor antagonists

This invention relates to novel compounds of Formula (I) to (VII), and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).